Richard Feelders Selected Research

Hormones (Hormone)

4/2004

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Feelders Research Topics

Disease

5	Adenoma (Adenomas) 01/2018 - 04/2004
3	Neoplasms (Cancer) 10/2021 - 12/2013
3	Prolactinoma (Prolactinomas) 10/2021 - 04/2004
3	Pituitary Neoplasms (Pituitary Adenoma) 02/2015 - 04/2004
2	Pituitary ACTH Hypersecretion 01/2018 - 04/2005
2	Cushing Syndrome 01/2018 - 01/2017
1	Hyperprolactinemia 10/2021
1	Rare Diseases (Rare Disease) 01/2017
1	Acromegaly 12/2013
1	ACTH-Secreting Pituitary Adenoma 04/2005
1	Growth Hormone-Secreting Pituitary Adenoma 04/2004

Drug/Important Bio-Agent (IBA)

3	ProlactinIBA 10/2021 - 04/2004
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2013 - 04/2004
3	Messenger RNA (mRNA)IBA 12/2013 - 04/2004
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017 - 04/2005
2	Octreotide (Sandostatin)FDA LinkGeneric 12/2013 - 04/2004
2	pasireotideIBA 04/2005 - 04/2004
1	ORALIT (ORS)IBA 10/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 10/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	GlucocorticoidsIBA 01/2017
1	G-Protein-Coupled Receptor Kinase 2IBA 12/2013
1	beta-Arrestin 1IBA 12/2013
1	ArrestinsIBA 12/2013
1	ArrestinIBA 12/2013
1	LigandsIBA 04/2005
1	somatostatin receptor 5IBA 04/2005
1	Hormones (Hormone)IBA 04/2004
1	Growth Hormone (Somatotropin)IBA 04/2004

Therapy/Procedure

2	Therapeutics 10/2021 - 02/2015
1	Aftercare (After-Treatment) 01/2018
1	Radiotherapy 02/2015